AbbVie's rheumatoid arthritis drug succeeds in trial

(Reuters) - AbbVie Inc said on Wednesday its oral rheumatoid arthritis drug succeeded in a late-stage study on patients who had not adequately responded to standard treatments.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news